Treatment of Type IV Renal Tubular Acidosis with Hyperkalemia and Metabolic Acidosis
Clinical Scenario
Type IV renal tubular acidosis (hyperkalemic RTA) is characterised by elevated serum potassium alongside metabolic acidosis. Correcting the potassium excess is central to resolving the acid-base disturbance in this presentation.
First-Line Approach — Overview Only
First-line management centres on dietary adjustments to potassium and acid-base balance, combined with a systematic review of the patient's current medication list for agents that may be contributing to impaired renal potassium handling. The full sequenced regimen — including specific dietary and medication criteria — is available in the complete protocol.
Treatment Goal
Reduction in serum potassium concentration with correction of metabolic acidosis.
References
DOI: 10.1007/s12325-020-01587-5
- In patients with hyperkalemic type 4 RTA, lowering of serum K+ concentrations often leads to correction of metabolic acidosis.
- Any non-essential medications affecting renal K+ excretion or aldosterone synthesis or activity should be discontinued.
- In patients with hyperkalemic RTA, dietary restriction of K+ has previously been the standard of care; however, new data suggest that increased intake of alkali-producing fruits and vegetables (which are often high in K+) and limiting intake of acid-producing foods may correct acidosis.
View source ↗